S'abonner

Three-Variate Longitudinal Patterns of Metabolic Control, Body Mass Index, and Insulin Dose during Puberty in a Type 1 Diabetes Cohort: A Group-Based Multitrajectory Analysis - 20/02/20

Doi : 10.1016/j.jpeds.2019.11.012 
Anke Schwandt, MS 1, 2, , Oliver Kuss, PhD 2, 3, 4, Desiree Dunstheimer, MD 5, Beate Karges, MD, PhD 6, Thomas Kapellen, MD, PhD 7, Thomas Meissner, MD 8, Michael Witsch, MD 9, Monika Flury, MD 10, Stefanie Straubinger, MD 11, Reinhard W. Holl, MD, PhD 1, 2
for the

Diabetes-Patienten-Verlaufsdokumentation (DPV) Initiative

1 Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany 
2 German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany 
3 Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany 
4 Institute of Medical Statistics, Heinrich-Heine-University, Medical Faculty, Düsseldorf, Germany 
5 Children's Hospital, University Hospital, Augsburg, Germany 
6 Division of Endocrinology and Diabetes, Medical Faculty, RWTH Aachen University, Aachen, Germany 
7 Department of Women and Child Health, University of Leipzig, Leipzig, Germany 
8 Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital, Heinrich Heine University Düsseldorf, Düsseldorf, Germany 
9 DECCP, Clinique Pédiatrique Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg 
10 Children's Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany 
11 Department of Pediatrics, Donauspital, Vienna, Austria 

Reprint requests: Anke Schwandt, MS, Institute of Epidemiology and Medical Biometry, Ulm University, ZIBMT Albert-Einstein-Allee 41, 89081 Ulm, Germany.Institute of Epidemiology and Medical BiometryUlm UniversityZIBMT Albert-Einstein-Allee 41Ulm89081Germany

Abstract

Objective

To analyze the interrelationship of metabolic control, age- and sex-adjusted body mass index, and daily insulin dose and to identify heterogeneous multivariate developmental curves from childhood to young adulthood in a large cohort of children with type 1 diabetes (T1D)

Study design

Data were extracted from the diabetes follow-up registry DPV. Longitudinal data from 9239 participants with T1D age 8-18 years with diabetes duration ≥2 years and ≥5 years of follow-up were analyzed. We applied group-based multitrajectory modeling to identify latent groups of subjects following similar developmental curves across outcomes (hemoglobin A1c [HbA1c], age/sex-standardized body mass index [BMI-SDS], daily insulin dose per kg). Group number was based on Bayes information criterion and group size (≥5%).

Results

The group-based multitrajectory approach revealed 5 heterogeneous 3-variate trajectories during puberty. Individuals with stable good metabolic control, high-normal increasing BMI-SDS, and rising insulin dose patterns were classified as group 1 (33%). Group 2 (20%) comprised youths with intermediate-increasing HbA1c, low BMI-SDS, and steeply increasing insulin dose trajectories. Group 3 (11%) followed intermediate-rising HbA1c and high-normal increasing BMI-SDS developmental curves, while insulin dose increased steeply. In group 4 (14%), both high-increasing HbA1c and insulin dose trajectories were observed, while BMI-SDS was stable-normal. Group 5 (22%) included subjects with intermediate-rising HbA1c patterns, high-increasing BMI-SDS, and increasing insulin dose patterns.

Conclusions

This study identified 5 distinct 3-variate curves of HbA1c, BMI-SDS, and insulin dose during puberty among youths with T1D. This approach demonstrates a considerable heterogeneity highlighting the importance of personalized medical care.

Le texte complet de cet article est disponible en PDF.

Keywords : multitrajectory group-based modeling, type 1 diabetes, puberty, HbA1c, body mass index, insulin dose

Abbreviations : BMI, CGM, DPV, GBMT, GBT, HbA1c, KiGGS, SMBG, T1D


Plan


 The DPV is supported through the German Federal Ministry for Education and Research within the German Center for Diabetes Research (DZD, grant number: 82DZD0017G). Further financial support was received by the German Robert Koch Institute (RKI) and the German Diabetes Association (DDG). Sponsors were not involved in study design, collection, analysis and interpretation of data, writing of the report, and the decision to submit the manuscript for publication. T.K. receives grants from EU Horizon 2020, from null, outside the submitted work. The other authors declare no conflicts of interest.


© 2019  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 218

P. 64 - mars 2020 Retour au numéro
Article précédent Article précédent
  • Long-Term Neurobehavioral and Quality of Life Outcomes of Critically Ill Children after Glycemic Control
  • Katherine V. Biagas, Veronica J. Hinton, Natalie R. Hasbani, Peter M. Luckett, David Wypij, Vinay M. Nadkarni, Michael S.D. Agus, HALF-PINT trial study investigators, the PALISI Network, Vijay Srinivasan, Peter M. Mourani, Ranjit Chima, Neal J. Thomas, Simon Li, Alan Pinto, Christopher Newth, Amanda Hassinger, Kris Bysani, Kyle J. Rehder, Edward Vincent Faustino, Sarah Kandil, Eliotte Hirshberg, Kupper Wintergerst, Adam Schwarz, Dayanand Bagdure, Lauren Marsillio, Natalie Cvijanovich, Nga Pham, Michael Quasney, Heidi Flori, Myke Federman, Sholeen Nett, Neethi Pinto, Shirley Viteri, James Schneider, Shivanand Medar, Anil Sapru, Patrick McQuillen, Christopher Babbitt, John C. Lin, Philippe Jouvet, Ofer Yanay, Christine Allen, Lisa Asaro, Kerry Coughlin-Wells, Jaclyn French, Aruna Natarajan
| Article suivant Article suivant
  • The Importance of Echocardiogram during the Second Week of Illness in Children with Kawasaki Disease
  • Shani Ma, So Yung Choi, Hyeong Jun Ahn, Andrea M. Siu, Marian E. Melish, Andras Bratincsak

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.